Why are We Vaccinating
Children Against COVID-19?
Note from Dr. Rima
“Whether or not you are concerned with jabbing children with the COVID jabs, this Paper’s clear and accessible discussion of the totally inadequate clinical trials for these injections is a MUST READ for everyone.
Skewed and dishonestly constructed clinical trials are a standard in the pharmaceutical industry. The new depths to which these mass innoculations have sunk is truly breathtaking – and perhaps breath taking as in lethal.
This congent and concise exposition of the unacceptable risks from forcing the COVID EUA inoculations into children is a must read for every person concerned with the devastation that the Declared Pandemic is causing in our society and those least able to assert their Informed Refusal. Future generations will hold us responsible if we do not protect the children from the mad vaxxers. www.DirectScience.com has provided an important public service by publishing this peer-reviewed paper with 127 citations to the scientific literature.”
- • Bulk of COVID-19 per capita deaths occur in elderly with high comorbidities.
- • Per capita COVID-19 deaths are negligible in children.
- • Clinical trials for theseinoculations were very short-term.
- • Clinical trials did not address long-term effects most relevant to children.
- • High post-inoculation deaths reported in VAERS (very short-term).
This article examines issues related to COVID-19 inoculations for children. The bulk of the official COVID-19-attributed deaths per capita occur in the elderly with high comorbidities, and the COVID-19 attributed deaths per capita are negligible in children. The bulk of the normalized post-inoculation deaths also occur in the elderly with high comorbidities, while the normalized post-inoculation deaths are small, but not negligible, in children. Clinical trials for these inoculations were very short-term (a few months), had samples not representative of the total population, and for adolescents/children, had poor predictive power because of their small size. Further, the clinical trials did not address changes in biomarkers that could serve as early warning indicators of elevated predisposition to serious diseases. Most importantly, the clinical trials did not address long-term effects that, if serious, would be borne by children/adolescents for potentially decades.
A novel best-case scenario cost-benefit analysis showed very conservatively that there are five times the number of deaths attributable to each inoculation vs those attributable to COVID-19 in the most vulnerable 65+ demographic. The risk of death from COVID-19 decreases drastically as age decreases, and the longer-term effects of the inoculations on lower age groups will increase their risk-benefit ratio, perhaps substantially.
The people with myriad comorbidities in the age range where most deaths with COVID-19 occurred were in very poor health. Their deaths did not seem to increase all-cause mortality as shown in several studies. If they hadn’t died with COVID-19, they probably would have died from the flu or many of the other comorbidities they had. We can’t say for sure that many/most died from COVID-19 because of: 1) how the PCR tests were manipulated to give copious false positives and 2) how deaths were arbitrarily attributed to COVID-19 in the presence of myriad comorbidities.
The graphs presented in this paper indicate that the frail injection recipients receive minimal benefit from the inoculation. Their basic problem is a dysfunctional immune system, resulting in part or in whole from a lifetime of toxic exposures and toxic behaviors. They are susceptible to either the wild virus triggering the dysfunctional immune system into over-reacting or under-reacting, leading to poor outcomes or the injection doing the same.
Read the Paper Here: